Executive Summary
Across 50 SEC 8-K filings from March 25, 2026, dominant themes include widespread board and executive transitions (24 instances of appointments, resignations, retirements across firms like Brand Engagement, Ingredion, HBT Financial, Comstock, Conduent, etc.), signaling proactive governance refreshes amid strategic pivots; robust debt management with 8 credit amendments/extensions (Cipher Mining, Synergy CHC, Senior Credit, Waste Management, Albemarle) enhancing liquidity; active M&A and asset transactions (Sandisk $1B Nanya stake, Fresh Del Monte $285M acquisition, Terns $6.7B Merck buyout, Hecla $160M mine sale); and financings (Apogee $377M equity, Blue Water $125M SPAC IPO, Ballston Spa $26M notes). Period-over-period trends are sparse but notable: Maze Therapeutics cash runway extended 83% YoY to $360M (runway to 2028) despite net loss widening to $131.1M from $52.2M profit (R&D +30% YoY, G&A +31%); CIMG Q1 FY2026 revenue exploded to $15.8M from $23k YoY (+69,000%); Generac FY2025 sales $4.2B with Residential EBITDA $558M. Positive sentiment prevails (28/50 filings), especially biotech/pharma (Maze Phase 2 success, Terns M&A) and energy/mining deleveraging; portfolio implications favor monitoring biotech catalysts and governance-improved names for alpha, while watching leadership vacuums and mixed financials like Maze/CIMG delisting risks.
Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from March 24, 2026.
Investment Signals(12)
- Cipher Mining Inc.↓(BULLISH)▲
Secured senior secured revolver with top lenders (Morgan Stanley, Goldman), margins Term SOFR +1.75% adjustable to +1.25%, positive liquidity signal
- Sandisk Corp↓(BULLISH)▲
$1B purchase of 3.9% Nanya stake at 15% discount to 30-day VWAP + multi-year DRAM supply deal, strategic sourcing locked in
- HBT Financial↓(BULLISH)▲
Appointed 40-year banking vet Michael Morton to board, bolstering $5.1B assets/$3.5B loans platform
- Maze Therapeutics↓(BULLISH)▲
Phase 2 HORIZON 35.6% mean uACR reduction (61.8% severe FSGS), cash $360M (+83% YoY from $196.8M), runway to 2028
- Terns Pharmaceuticals↓(BULLISH)▲
Merck $6.7B acquisition at $53/share (31% premium to 60-day VWAP), expands CML pipeline with Phase 1/2 TERN-701
- Generac Holdings↓(BULLISH)▲
FY2025 prelim net sales $4.2B (Residential $2.5B EBITDA $558M, C&I $1.8B EBITDA $200M), Adjusted EBITDA $716M
- Fresh Del Monte Produce↓(BULLISH)▲
Completed $285M Del Monte assets acquisition (global brand, US/Mexico/Venezuela facilities), reunites brand for efficiency gains
- Comstock Inc.↓(BULLISH)▲
Added 3 independent directors (Colvin, Spence, Pei) post-shareholder dialogue, strengthens solar recycling governance
- Athena Technology Acquisition II(BULLISH)▲
SPAC BCA amendment adds earnouts up to 25.5M shares ($15-25 VWAP/revenue/EBITDA), Sponsor share surrender aids PIPE
- CIMG Inc.↓(BULLISH)▲
Q1 FY2026 revenue $15.8M vs $23k YoY (+69,000%), 730 BTC holdings $64M, new computing/medicine-food segments
- Hecla Mining↓(BULLISH)▲
Casa Berardi sale yields $160M cash +65.8M Orezone shares +$321M contingent, full $263M 2028 notes redemption April 9
- Apogee Therapeutics↓(BULLISH)▲
$377.4M gross from 5.75M shares at $70/share (underwriters full exercise), funds clinical pipeline
Risk Flags(10)
- Maze Therapeutics/Financial Deterioration↓[HIGH RISK]▼
FY2025 net loss $131.1M vs $52.2M profit YoY (no license rev vs $167.5M, R&D +30%, G&A +31%)
- CIMG Inc./Compliance↓[MEDIUM RISK]▼
Nasdaq delisting risk amid appeal, despite rev surge; BTC holdings $64M volatile
- Brand Engagement Network/Leadership Vacuum↓[MEDIUM RISK]▼
Chairman Puckett steps down March 31, no disagreements but transition timing
- Ingredion Inc./CFO Transition↓[MEDIUM RISK]▼
CFO Gray resigns March 31, interim Payant appointed; prior IR interim experience but untested at CFO scale
- Conduent Inc./Exec Termination↓[HIGH RISK]▼
CTO Prout terminated without cause March 24, no successor named, severance undisclosed
- Texas Instruments/Exec Retirement↓[MEDIUM RISK]▼
SVP Kozanian retires Aug 31, no successor info, potential ops disruption
- Nuburu Inc./Regulatory↓[HIGH RISK]▼
Tekne 70% acquisition LOI risks Italian Golden Power delays, restructuring/spin-off uncertainties
- Twin Vee PowerCats/Dilution↓[MEDIUM RISK]▼
$2.5M ATM 6.5M shares at $0.384, working capital raise signals cash burn
- Annovis Bio/Leadership↓[MEDIUM RISK]▼
CFO Guerin departs March 23, CEO as acting CFO until replacement
- Calumet Inc./Governance↓[LOW RISK]▼
Director Straumins retires at 2026 AGM, board evaluating amid 12 North America facilities ops
Opportunities(10)
- Terns Pharmaceuticals/M&A Arbitrage↓(OPPORTUNITY)◆
Merck deal closes Q2 2026 post-antitrust/tender, 42% premium to 90-day VWAP, low DLTs in CARDINAL trial
- Maze Therapeutics/Clinical Catalysts↓(OPPORTUNITY)◆
Phase 2 MZE782 POC trials mid-2026 (PKU)/H2 (CKD), post-HORIZON 35.6% uACR cut, $360M cash
- Hecla Mining/Deleveraging↓(OPPORTUNITY)◆
$160M cash from mine sale funds $263M notes redemption April 9, boosts flexibility as top silver producer
- Sandisk Corp/Strategic Stake↓(OPPORTUNITY)◆
139M Nanya shares (3.9% FD) at 15% discount + DRAM supply, 3-year lock-up stabilizes sourcing
- Blue Water Acquisition IV/SPAC IPO(OPPORTUNITY)◆
$125M IPO priced March 23 at $10/unit (12.5M units), NYSE listing BWIV.U, 45-day over-allotment
- Apogee Therapeutics/Capital Raise↓(OPPORTUNITY)◆
$377M at $70/share funds pipeline, strong pricing vs shelf indicates demand
- Generac Holdings/Resi Strength↓(OPPORTUNITY)◆
FY2025 Residential $2.5B sales/$558M EBITDA outperforms C&I, watch power demand trends
- Comstock Inc./Governance Refresh↓(OPPORTUNITY)◆
New directors (ex-CFOs/PE) + Non-Exec Chairman to 2027, solar metals growth post-shareholder push
- BioLargo Inc./ATM Facility↓(OPPORTUNITY)◆
$10M commitment shares deal over 36 months, flexible working capital at 9.99% ownership cap
- Ballston Spa Bancorp/Merger Funding↓(OPPORTUNITY)◆
$26M 7.375% notes for NBC Bancorp merger, Tier 2 capital to 2036
Sector Themes(6)
- Governance Refresh Wave(GOVERNANCE UPGRADE)◆
24/50 filings (48%) detail board/exec changes (e.g., Comstock 3 adds, PayPal new director, 12 retirements like ONEOK/Calumet), implying shareholder-driven improvements and stability; positive for long-term value creation vs stagnant peers
- Debt Facility Extensions/Amendments(LIQUIDITY STRENGTH)◆
8 firms (Cipher, Synergy, Senior Credit, Waste Mgmt, Albemarle, etc.) extended maturities/pricing grids (e.g., Albemarle to 2028/29, Waste Mgmt EBITDA add-backs), aggregate trend signals strong lender confidence and liquidity health vs tightening credit environments
- Biotech/Pharma Pipeline Momentum(CATALYST RICH)◆
6 filings (Maze 35.6% Phase 2 success, Terns $6.7B M&A, Recursion CMO hire, Apogee $377M raise) show clinical advances/appointments; contrasts mixed FY losses (Maze R&D +30% YoY), positions sector for 2026 catalysts
- M&A/Asset Deals Accelerating◆
8 transactions (Sandisk $1B stake, Fresh Del Monte $285M, Hecla $160M sale + redemption, Nuburu LOI) at premiums/discounts, deleveraging (Hecla) and brand synergies; outliers like Terns 31% premium highlight undervalued targets [M&A ALPHA]
- Equity Financings Surge(CAPITAL INFLOW)◆
7 raises (Apogee $377M, Blue Water $125M SPAC, BioLargo $10M facility, Twin Vee $2.5M ATM) at solid pricing ($70/share Apogee), funds growth amid volatility; CIMG BTC $64M adds crypto exposure
- Mixed Financial Momentum(GROWTH VS COSTS)◆
Where reported, revenue outliers (CIMG +69k% YoY, Generac $4.2B) but losses widen (Maze $131M vs profit); cash builds (Maze +83% YoY) support runways, flags capex/R&D ramps vs flat peers
Watch List(8)
- Maze Therapeutics/Conf Call↓(MONITOR CLOSELY)👁
Topline Phase 2 details, MZE782 trial starts mid/H2 2026, FY loss drivers; March 25 8am EDT
- Terns Pharmaceuticals/Close↓(MONITOR CLOSELY)👁
Merck tender/antitrust approval for Q2 2026 close, CARDINAL expansion data; watch litigation risks
- Hecla Mining/Redemption↓(MONITOR CLOSELY)👁
$263M notes redeem April 9 post-mine sale, deleveraging impact on silver ops (Greens Creek/Keno Hill)
- Prairie Operating/Payment↓(MONITOR CLOSELY)👁
$3M to Series F buyers April 6 unless waived, Anniversary Warrants April 7 on $148M preferred
- Apogee Therapeutics/Close↓(MONITOR)👁
$377M offering closes March 26, pipeline funding allocation post-shelf
- Athena Technology Acq II/Earnouts(MONITOR)👁
SPAC post-close price/revenue triggers ($15-25 VWAP, $75M rev FY1), board changes
- CIMG Inc./Delisting Appeal↓(MONITOR)👁
Nasdaq compliance + BTC volatility on $64M holdings, Q1 rev sustainability
- Nuburu Inc./Regulatory↓(MONITOR)👁
Tekne LOI Italian Golden Power auth, restructuring/drone spin-off timelines
Filing Analyses(50)
25-03-2026
Cipher Digital Inc., a subsidiary of Cipher Mining Inc., entered into a senior secured revolving credit agreement dated March 23, 2026, with a lender syndicate led by Morgan Stanley Senior Funding, Inc. as Administrative Agent and Collateral Agent, and joint arrangers including Banco Santander, Goldman Sachs Lending Partners LLC, JPMorgan Chase Bank, N.A., Sumitomo Mitsui Banking Corporation, and Wells Fargo Securities, LLC. Proceeds are for working capital and general corporate purposes, with interest margins starting at Term SOFR +1.750% / ABR +0.750% (adjustable down to +1.250% / +0.250% based on Consolidated Total Debt to Market Capitalization Ratio <0.30x) and a 0.50% commitment fee; no facility size or drawdowns specified.
- ·Pricing grid based on Consolidated Total Debt to Market Capitalization Ratio: Level 1 (<0.30:1) 1.250%/0.250%; Level 2 (0.30-0.60:1) 1.500%/0.500%; Level 3 (>0.60:1) 1.750%/0.750% for Term SOFR/ABR.
- ·Initial pricing effective until Compliance Certificate for fiscal quarter ending September 30, 2026.
- ·Alternate Base Rate defined as highest of 1.00%, Prime Rate, Federal Funds Effective Rate + 0.50%, or Adjusted Term SOFR (1-month) + 1.00%.
25-03-2026
Sandisk Technologies, Inc., a wholly-owned subsidiary of Sandisk Corporation, entered into a Private Placement Subscription Agreement with Nanya Technology Corporation on March 25, 2026, to purchase approximately 139 million shares of Nanya common stock for $1.0B, representing 3.9% of Nanya’s outstanding common stock on a fully diluted basis at a 15% discount to the 30-day average trading price. Concurrently, the companies entered a multi-year strategic supply arrangement for Nanya to supply DRAM products to support Sandisk's long-term sourcing strategy. The transaction shares are subject to a statutory 3-year lock-up period under Taiwanese law.
- ·Transaction conducted pursuant to Article 43-6 of the Taiwan Securities and Exchange Act, subject to post-closing filings with Taiwan Stock Exchange and other regulators.
- ·Shares subject to statutory 3-year lock-up from delivery, with limited transfer exceptions under Taiwanese law.
25-03-2026
Brand Engagement Network Inc. announced that Bernard Puckett notified the Board he will step down as Chairman and resign as a director effective March 31, 2026, after serving as Interim Chairman since August 2025 and Board member since April 2023; his departure is not due to any disagreements. The Board appointed independent director Jon Leibowitz as the new Chairman effective April 1, 2026. Mr. Leibowitz brings extensive experience from roles at the Federal Trade Commission, Davis Polk & Wardwell LLP, and as Chairman of the National Consumers League.
- ·Puckett served as Chair of the Audit Committee and member of Compensation Committee and Nominating and Corporate Governance Committee.
- ·Leibowitz currently serves as Chair of the Nominating and Corporate Governance Committee and member of the Audit Committee.
- ·Resignation letter from Puckett dated March 20, 2026, attached as Exhibit 17.1.
25-03-2026
On March 18, 2026, Ingredion Incorporated's Board of Directors elected Jason Payant as Interim Chief Financial Officer effective April 1, 2026, succeeding James D. Gray, whose resignation as EVP and CFO was effective March 31, 2026. Mr. Payant, age 55, has served the company since 2012 in various senior finance roles, including Vice President, Finance, Global Texture & Healthful Solutions since November 2025. He will receive $25,000 monthly cash compensation in addition to his existing compensation and benefits during his interim tenure.
- ·Jason Payant previously served as Vice President, Finance, Food & Industrial Ingredients U.S./Canada from January 2024 to November 2025, Interim Vice President, Investor Relations from September 2021 to October 2022, and Vice President, Finance from October 2017 to January 2024.
- ·No arrangements or understandings with other persons for Mr. Payant's selection; no material transactions involving Mr. Payant or his family.
- ·James D. Gray's resignation reported on January 27, 2026.
25-03-2026
HBT Financial, Inc. announced the appointment of Michael J. Morton to the Board of Directors of HBT Financial and Heartland Bank, effective April 1, 2026, with his initial term expiring at the 2026 Annual Meeting of Stockholders. Mr. Morton brings nearly 40 years of banking experience, including as Vice Chair of U.S. Commercial Banking at BMO (2020-2023) and Executive Vice President and Chief Credit Officer at MB Financial (2014-2019). As of December 31, 2025, HBT Financial reported total assets of $5.1B, total loans of $3.5B, and total deposits of $4.4B.
- ·HBT Financial operates 83 full-service branches in Illinois, eastern Iowa, and suburban St. Louis.
- ·Mr. Morton holds a BS from Illinois State University and an MBA from DePaul University.
- ·Contact: HBTIR@hbtbank.com, (309) 664-4556
25-03-2026
Maze Therapeutics announced positive topline Phase 2 HORIZON data for MZE829 in broad AMKD, with a 35.6% mean uACR reduction at week 12 (61.8% in severe FSGS patients), supporting advancement to a pivotal program, alongside plans for two Phase 2 trials of MZE782 in PKU and CKD in 2026. Cash position strengthened to $360.0M as of Dec 31, 2025 (up from $196.8M in 2024), providing runway into 2028, and Neil Kumar, Ph.D. was appointed to the Board. However, FY2025 net loss widened to $131.1M from a $52.2M profit in 2024, driven by no license revenue (vs. $167.5M in 2024) and increases in R&D expenses (30%) and G&A expenses (31%).
- ·No serious adverse events or severe treatment-related AEs observed in HORIZON trial.
- ·MZE782 Phase 2 POC trials to initiate mid-2026 (PKU) and H2 2026 (CKD).
- ·Conference call held March 25, 2026 at 8:00 am EDT.
- ·Tiered royalties from Shionogi: low double-digits to 20% on net sales.
25-03-2026
Merck announced a definitive agreement to acquire Terns Pharmaceuticals for $53.00 per share in cash, valuing the equity at approximately $6.7B ($5.7B net of cash), a 31% premium to the 60-day VWAP and 42% to the 90-day VWAP as of March 24, 2026. The deal expands Merck's hematology pipeline with TERN-701, an investigational oral allosteric BCR::ABL1 TKI in Phase 1/2 for CML, expected to close in Q2 2026 subject to antitrust approval and tender offer conditions, resulting in a $5.8B charge ($2.35/share) to Merck's Q2 and FY2026 results. While promising early clinical data shows encouraging responses and low adverse events, the transaction carries risks including regulatory delays and shareholder litigation.
- ·Dose escalation of CARDINAL trial completed January 2025 with no dose-limiting toxicities up to 500mg QD.
- ·Dose expansion initiated April 2025 with 320mg or 500mg QD cohorts (up to 40 patients each).
- ·Additional CARDINAL cohort added January 2026 for BCR::ABL1 resistance mutations (e.g., T315I) in ~20 patients.
- ·FDA granted Orphan Drug Designation for TERN-701 in CML in March 2024.
- ·Merck investor call held March 25, 2026 at 8 a.m. EDT.
- ·Transaction via tender offer; merger agreement to be filed with SEC.
25-03-2026
Apimeds Pharmaceuticals US, Inc. (APUS) filed an 8-K on March 25, 2026, disclosing the Second Amendment to its Bylaws dated March 20, 2026, under Items 5.02 (Director/Officer Departure/Election), 5.03 (Bylaws Amendment), 8.01, and 9.01. The amendments restate Section 17 to require Board vacancies to be filled solely by the affirmative vote of a majority of shares of capital stock entitled to vote at a stockholders' meeting or by written consent. Section 47 is restated to empower both the Board (by majority of authorized directors) and stockholders (by majority vote) to adopt, amend, or repeal the Bylaws.
- ·Filing Items: 5.02 (Director/Officer Departure/Election), 5.03 (Amendments to Bylaws), 8.01 (Other Events), 9.01 (Exhibits)
25-03-2026
Generac Holdings Inc. disclosed preliminary full-year 2025 financial results via Exhibit 99.1 in an 8-K filing, reporting net sales of $4.2B and Adjusted EBITDA of $716M for the twelve months ended December 31, 2025. The Residential segment led with $2.5B in net sales and $558M in Adjusted EBITDA, while the Commercial & Industrial segment contributed $1.8B in sales but a lower $200M in Adjusted EBITDA. Income before provision for income taxes totaled $199M after significant adjustments including $158M in legal/regulatory provisions and $71M in interest expense.
- ·Interest expense: $71M
- ·Depreciation and amortization: $195M
- ·Provision for legal, regulatory, and other costs: $158M
- ·Non-cash share-based compensation expense: $50M
- ·Change in fair value of investments: $21M
25-03-2026
Fresh Del Monte Produce Inc. (NYSE: FDP) completed the acquisition of select assets from Del Monte Foods Corporation II Inc. for approximately $285 million, reuniting the Del Monte® brand under one owner for the first time in nearly four decades and expanding its prepared and packaged foods platform. The transaction includes global ownership of the Del Monte® brand (subject to existing licenses), brands such as S&W®, Contadina®, and packaged vegetables/tomatoes/refrigerated fruits, plus manufacturing facilities in the US, Mexico, and Venezuela. While expected to enhance brand consistency, efficiency, and growth, forward-looking statements note integration risks including operational disruptions and additional indebtedness.
- ·Acquisition approved by U.S. Bankruptcy Court for the District of New Jersey under Section 363 of the U.S. Bankruptcy Code.
- ·Funded via cash on hand and revolving credit facility availability.
- ·Excludes canned fruit and ambient packaged fruit/fruit sauce products for U.S., Puerto Rico, Mexico; physical assets for those businesses.
- ·Dedicated business unit for acquired brands/businesses to ensure operational continuity; no immediate changes to products, packaging, or distribution.
- ·Rabobank (financial advisor), Greenberg Traurig and Dickinson Wright (legal advisors) to Fresh Del Monte.
- ·Integration progress and financial expectations to be shared in Q1 2026 earnings call.
25-03-2026
Hagop Kozanian, Senior Vice President of Texas Instruments Incorporated (TXN), announced his intention to retire effective August 31, 2026, as disclosed in an 8-K filing on March 25, 2026. The filing was signed by Katharine Kane, Senior Vice President, Secretary and General Counsel. No information on a successor or any financial impact was provided.
- ·Company headquarters: 12500 TI Boulevard, Dallas, Texas 75243
- ·Registrant’s telephone number: (214) 479-3773
- ·Common Stock, par value $1.00, trading symbol TXN on The Nasdaq Global Select Market
25-03-2026
Comstock Inc. appointed three new independent directors—Donald A. Colvin (effective immediately, to join Audit and Finance Committee), Robert M. Spence (effective immediately, Chair of Audit and Finance and Compensation Committees), and Steven Y. Pei (effective April 15, 2026)—to strengthen governance amid growth in solar recycling and critical metals recovery. Walter 'Del' Marting Jr. will serve as Non-Executive Chairman through the 2027 Annual Meeting, after which Kristin Slanina assumes the role, while William J. Nance and Marting committed not to stand for re-election. These changes followed constructive dialogue with significant shareholders MAK Capital Fund LP and Gratia Capital LLC.
- ·Colvin's prior CFO roles at Caesars Entertainment, ON Semiconductor, Atmel, and others; serves on boards of Maxeon Solar Technologies, Viavi Solutions, Agilysys.
- ·Pei founded Gratia Capital in 2012; prior roles at Canyon Capital, Bain Capital, McKinsey.
- ·Spence currently Director at Ecobat (battery recycling); prior General Counsel at Skyline Champion and Neenah Enterprises.
- ·Company uses www.comstock.inc, X.com, LinkedIn, YouTube for Regulation FD disclosures.
25-03-2026
Conduent Incorporated terminated the employment without cause of Mark Prout, Executive Vice President and Chief Information and Technology Officer, effective March 24, 2026. Mr. Prout is entitled to compensation and benefits under the Company's U.S. Executive Severance Policy. No successor was named and no financial details on severance were disclosed.
25-03-2026
Athena Technology Acquisition Corp. II (SPAC) and Ace Green Recycling, Inc. executed the First Amendment to their December 4, 2024 Business Combination Agreement on March 19, 2026, revising earnout terms to provide up to 25,500,000 Earnout Shares to eligible equityholders upon achieving stock price thresholds ($15-$25 VWAP), $75,000,000 revenue in the first full fiscal year post-Closing, or $50,000,000 aggregate EBITDA over five years, with 1,500,000 Sponsor Earnout Shares vesting on select price triggers. The Sponsor surrendered 6,335,000 SPAC Shares to support PIPE financing efforts, and prior escrow deposits of 1,000,000 and 750,000 shares were revoked. Amendments also adjust post-Closing board to six members (five nominated by Company), relax no-shop covenants for permitted capital raises, and clarify Change of Control implications.
- ·Earnout triggers include 20 Trading Days VWAP >= $15 (Event I/VI), $20 (Events II/VI-VII), $25 (Events III/VI-VIII) within 30-day period during Adjusted Earnout Period (6-month to 3-year post-Closing).
- ·Change of Control deems price-based triggers at $15/$20/$25 thresholds and adjusts revenue/EBITDA tests to acquiring entity statements.
- ·Post-Closing SPAC Board: 5 nominees from Company, 1 from SPAC; all pre-Closing directors resign.
- ·Permitted Transactions (capital raises like PIPE, debt/equity sales) excluded from Alternative Transaction prohibitions.
25-03-2026
On March 20, 2026, Rodger R. Schwecke, Chief Operating Officer of Southern California Gas Company (a subsidiary of Sempra), provided notice of his retirement effective August 1, 2026, after more than 44 years of service with the Sempra family of companies. The Form 8-K was filed on March 25, 2026, and signed by Maryam S. Brown, Chief Executive Officer and President. No financial impacts or successor details were disclosed.
- ·No successor named for the COO position.
- ·Registrant details: California incorporation, Commission File Number 1-0140, IRS EIN 95-1240705.
25-03-2026
Synergy CHC Corp., along with guarantors Synergy CHC Inc. and HAND MD CORP., entered into a Second Amendment to its Term Loan Credit Agreement on March 24, 2026, with ACP Agency, LLC serving as administrative and collateral agent. The amendment requires the issuance of a Common Stock Purchase Warrant to the lender, execution of an Amended and Restated Fee Letter, and payment of a $55,000 KTBS Installment Fee to KTBS Law LLP. No specific changes to loan terms or financial metrics are detailed in the filing.
- ·Original Term Loan Credit Agreement dated May 30, 2025
- ·First Amendment dated June 24, 2025
- ·SEC 8-K filing date: March 25, 2026
- ·Items reported: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), 9.01 (Financial Statements and Exhibits)
25-03-2026
On March 23, 2026, Jae A. Evans resigned from the Board of Directors of Isabella Bank Corporation and its subsidiary Isabella Bank, effective as of the close of business on that date. There is no disagreement, known to an executive officer of the Corporation, between the Corporation and Mr. Evans on any matter relating to the Corporation’s operations, policies, or practices. The 8-K filing was submitted on March 25, 2026.
25-03-2026
Calumet, Inc. (NASDAQ: CLMT) announced that Board member Jennifer Straumins will not seek re-election and retire at the end of her current term, expiring at the 2026 Annual Meeting of Stockholders. Straumins joined the Board in July 2024, previously served on Calumet GP, LLC's board from February 2021 to July 2024, and was an employee for 13 years, contributing to Strategy and Growth and Risk Committees. Leadership expressed gratitude for her contributions, with the Board to evaluate composition for strategic alignment.
- ·Headquartered in Indianapolis, Indiana; operates twelve facilities throughout North America.
- ·Investor contact: John Kompa (317-957-5237, John.Kompa@calumetspecialty.com).
- ·Public Relations contact: Media Oakes (317-957-5319, Media.Oakes@calumetspecialty.com).
25-03-2026
Prairie Operating Co. entered into an Amendment to its Securities Purchase Agreement dated March 25, 2026, with the Buyers of its previously issued 148,250 shares of Series F Preferred Stock (stated value $1,000 per share, totaling $148.25M). The amendment changes the Anniversary Warrant Issuance Date to April 7, 2026, updates related references, and obligates the Company to pay an aggregate $3M to the Buyers on April 6, 2026, unless waived by the Buyers.
- ·Warrants to purchase Common Stock equal to 125% of the Stated Value of held Series F Preferred Stock divided by the average of the 10 daily VWAPs prior to original issuance date, issuable April 7, 2026 subject to conditions.
- ·Original Purchase Agreement dated March 26, 2025.
25-03-2026
Cheetah Net Supply Chain Service Inc. entered into a Stock Purchase Agreement on March 25, 2026, to sell all 10,000 shares of its wholly-owned subsidiary, Edward Transit Express Group, Inc., to Bing Shao for an aggregate purchase price of $20,000 in cash. The transaction aims to streamline operations, reduce the adverse impact of the subsidiary's ocean package transportation and freight forwarding business on the company's results, and enable focus on new strategic acquisition opportunities. Closing is expected within 20 calendar days of execution.
- ·Includes execution of a Support and Restrictive Covenant Agreement with mutual non-disparagement obligations and a general release of claims by the Seller against the Subsidiary.
- ·Shares to be sold free and clear of any liens other than transfer restrictions imposed by applicable securities laws.
25-03-2026
On March 19, 2026, the Boards of Directors of Orange County Bancorp, Inc. and its wholly owned subsidiary Orange Bank & Trust Company amended the employment agreement of President and CEO Michael J. Gilfeather, extending it through March 31, 2029, with no other changes. They also amended his Performance-Based Supplemental Executive Retirement Plan Participation Agreement to provide a discretionary $125,000 employer contribution for the 2028 Plan Year, which will cliff vest on March 30, 2029. The amendments will be filed as exhibits in the Company's Form 10-Q for the quarter ending March 31, 2026.
- ·Amendments executed on March 19, 2026; filing dated March 25, 2026
25-03-2026
ONEOK, Inc. (NYSE: OKE) announced that directors Gerald B. Smith and Pattye L. Moore will retire from the board at the end of their current terms on May 20, 2026, coinciding with the 2026 Annual Meeting of Shareholders. Smith, who joined in 2020, is retiring per the company's mandatory director retirement age policy, while Moore, a board member since 2002, has elected to retire. Company leadership expressed gratitude for their contributions during ONEOK's significant transformation into a leading midstream operator.
- ·ONEOK is headquartered in Tulsa, Oklahoma and is an S&P 500 company.
- ·Investor Relations contact: Megan Patterson (918-561-5325, ONEOKInvestorRelations@oneok.com).
- ·Media Relations contact: Charlsey Phillips (918-510-1664, Media@oneok.com).
25-03-2026
On March 19, 2026, Lindblad Expeditions Holdings, Inc. appointed Rear Admiral Keith Taylor (Ret.), its Chief Maritime Officer, as an executive officer. Mr. Taylor, who joined the company in April 2025, brings over 30 years of U.S. Coast Guard experience and prior leadership as EVP of Fleet Operations for Carnival Corporation subsidiaries, managing 41 cruise ships. His compensation package includes an initial base salary of $330,000, with target annual cash bonus and equity awards each equal to 75% of base salary.
- ·Mr. Taylor, age 64, was Principal of Keith A. Taylor & Associates LLC from January 2023 to March 2025.
- ·Prior roles include Commander of the 13th Coast Guard District and various command, operational, and engineering assignments in U.S. Coast Guard.
- ·Education: Master of Business Administration (Sloan Fellow) from Massachusetts Institute of Technology, Master of Science in Industrial Administration from Purdue University, U.S. Coast Guard Academy graduate with honors.
- ·No arrangements or understandings with other persons for appointment; no family relationships with directors/officers; no material interests under Item 404(a) of Regulation S-K.
25-03-2026
CIMG Inc. reported Q1 FY2026 revenue of $15,768,796, up dramatically from $22,853 in the prior-year period, driven by expansion into medicine-food homology products and new computing power solutions with clients including China Merchants Bank. The company held 730 Bitcoins valued at $63,978,821 as of December 31, 2025, though subject to significant market volatility, and book value per share stood at $3.6. While advancing strategic transformation with new subsidiaries and acquisitions, CIMG faces Nasdaq delisting risks and is appealing a compliance decision.
- ·Established wholly-owned subsidiaries in Shenzhen and Foshan, China.
- ·Acquired Braincon Limited (HK) and its subsidiary Beijing Xin Miao Shi Dai Technology Development Co., Ltd.
- ·Computing power product series launched in September 2025.
- ·Filed appeal against Nasdaq delisting decision.
25-03-2026
Jefferies Credit Partners BDC Inc. sold 734,811.134 unregistered Class I common shares and 6,095.445 Class S common shares at a NAV of $14.43701 per share (as of February 28, 2026), raising $10,608,475.60 and $88,000.00 respectively from third-party investors, exempt under Section 4(a)(2), Regulation D, and/or Regulation S. On March 19, 2026, the board appointed Ryan Schindele as permanent Chief Financial Officer, following his role as Interim CFO since September 30, 2025.
- ·Share sales based on NAV as of February 28, 2026, with final number of shares determined on March 20, 2026
- ·Ryan Schindele served as Interim CFO since September 30, 2025; no family relationships, arrangements, or reportable transactions under Item 404(a) of Regulation S-K
25-03-2026
Recursion Pharmaceuticals (Nasdaq: RXRX) announced Vicki Goodman, M.D., as incoming Chief Medical Officer effective April 6, 2026, succeeding David Mauro, M.D., Ph.D., who is transitioning out after approximately three years. Dr. Goodman brings over two decades of oncology drug development experience from roles at Mural Oncology, Exelixis, Merck, Bristol Myers Squibb, and GlaxoSmithKline, including oversight of KEYTRUDA, OPDIVO, YERVOY, and dabrafenib. The leadership transition is framed as strengthening Recursion's clinical pipeline advancement toward key milestones, with praise for Dr. Mauro's contributions including REC-4881 progression.
- ·Announcement date: March 25, 2026
- ·Dr. Goodman's education: M.D. from Albert Einstein College of Medicine; training at University of Michigan
- ·Dr. Goodman's early career: FDA Medical Officer
- ·Recursion locations: Salt Lake City, Utah; Milton Park, Oxfordshire; New York; Montréal; London
25-03-2026
Senior Credit Investments, LLC entered into the First Amendment to its Revolving Credit Agreement, originally dated March 21, 2025, with Sumitomo Mitsui Trust Bank, Limited, New York Branch as Administrative Agent, Arranger, and Lender, effective as of March 20, 2026. The amendment extends the Stated Maturity Date and makes other unspecified changes to the agreement. The filing confirms no Default or Event of Default exists post-amendment, with representations and warranties remaining true.
- ·Amendment requires execution by Borrower, Administrative Agent, and all Lenders; receipt of Amended and Restated Fee Letter; and payment of fees and expenses.
- ·Credit Agreement amended via Annex A (deletions and additions indicated by strikethrough and double-underline).
- ·Governed by New York law.
25-03-2026
On March 20, 2026, Waste Management, Inc. entered into Amendment No. 2 to its Seventh Amended and Restated Revolving Credit Agreement originally dated May 8, 2024. The amendment modifies the definitions of EBIT and EBITDA to include add-backs for equity-based compensation and interest accretion as non-cash items in the leverage ratio financial covenant calculation under Section 9. This change aims to enhance comparability with industry peers' covenant treatments.
- ·Amendment filed as Exhibit 10.1
- ·Credit Agreement among Company, Waste Management of Canada Corporation and WM Quebec Inc. as Borrowers, with Bank of America, N.A. as Administrative Agent
25-03-2026
Civeo Corporation announced that director Charles Szalkowski notified the Board of his retirement effective at the 2026 annual general meeting, with no disagreement on operations, policies, or practices. He will continue serving until the meeting. As previously disclosed, the Board size will be reduced to nine directors effective at the 2026 Annual Meeting.
- ·Announcement previously disclosed Board size reduction on November 28, 2025
25-03-2026
The Trade Desk, Inc. (Nasdaq: TTD) announced the appointment of Drew Vollero, Reddit's CFO, to its Board of Directors on March 25, 2026. Vollero brings over three decades of financial and operational experience, including prior CFO roles at Allied Universal and Snapchat, where he guided IPOs and scaling efforts. CEO Jeff Green praised Vollero's expertise in helping high-growth tech companies navigate complex markets and deliver long-term value.
- ·Reddit IPO guided by Vollero in March 2024.
- ·Vollero holds B.A. in mathematics and economics from Yale University (magna cum laude) and M.S. in management from Oxford University.
- ·The Trade Desk headquartered in Ventura, CA, with offices in North America, Europe, and Asia Pacific.
25-03-2026
Albemarle Corporation entered into the Third Amendment to its 2022 Credit Agreement on March 19, 2026, extending the maturity date to the later of October 28, 2028 or one year thereafter under certain conditions. The amendment also deletes a 0.10% adjustment for SOFR-based loan interest calculations and reduces the number of allowable maturity date extension requests from two to one. No financial amounts or performance metrics were disclosed.
- ·Previous amendments to the 2022 Credit Agreement occurred on February 9, 2024 and October 31, 2024.
- ·The Third Amendment is filed as Exhibit 10.1.
25-03-2026
On March 23, 2026, Better Home & Finance Holding Company elected Hugh R. Frater as a director and member of the Board’s audit committee, effective immediately, with the Board confirming his independence under Nasdaq rules. Mr. Frater’s term expires at the 2026 annual stockholder meeting or until his successor is qualified. He will receive compensation per the Company’s Director Compensation Policy, including annual cash and equity retainers of $150,000 each, plus $7,500 each for audit committee service, prorated from commencement.
- ·Cash retainers paid quarterly in arrears; equity retainers vest on business day preceding annual stockholder meeting.
- ·Compensation prorated to reflect Mr. Frater’s service commencement date.
- ·Mr. Frater to enter standard indemnification agreement; no arrangements/understandings for selection, no family relationships, no material interests under Item 404(a) of Regulation S-K.
25-03-2026
SentinelOne, Inc. appointed Barry Padgett, age 55 and current Chief Growth Officer, as President and Chief Operating Officer effective March 24, 2026, following his role as interim Chief Financial Officer from January to March 2026. Compensation includes an annual base salary of $600,000, target annual cash bonus of 100% of base salary, and $10.0 million in RSU and PSU awards vesting starting August 5, 2026, with PSUs tied to performance metrics through fiscal 2030. No family relationships or reportable transactions under Item 404(a).
- ·Barry Padgett previously served as CEO of Amperity (March 2022-June 2024), President and COO at Amperity (April 2020-February 2022), Chief Revenue Officer at Stripe (March 2019-April 2020), and President of SAP SE (November 2016-February 2019).
- ·RSUs vest 1/16th on August 5, 2026 and each subsequent monthly Vesting Date (5th of month).
- ·PSUs vest based on performance metrics for FY ending Jan 31, 2027-2030, certified by Compensation Committee no later than April 30 following each year.
- ·Equity grant calculated using trailing 30-day average closing price up to April 15, 2026.
25-03-2026
Lifeward Ltd. executed a First Amendment to its January 12, 2026 Share Purchase Agreement with Oramed Pharmaceuticals Inc. to acquire Oratech, assigning rights from Oratech Pharma, Inc. (Nevada corporation) to Oratech Ltd. (Israeli company) and updating share definitions and capital structure. The amendment specifies that Oratech Ltd. has authorized capital of 1,000 Company Ordinary Shares, all issued and outstanding with none in treasury. This procedural update supports the completion of the acquisition as disclosed in the 8-K filing.
- ·Original Share Purchase Agreement dated January 12, 2026
- ·Amendment governed by laws of the State of Delaware
- ·8-K Items: 2.01, 3.02, 5.02, 9.01; Filing Date: March 25, 2026
25-03-2026
New Fortress Energy Inc. filed a Certificate of Elimination to remove all references to its 4.8% Series A Convertible Preferred Stock (96,746 authorized shares, filed March 20, 2024) and 4.8% Series B Convertible Preferred Stock (96,746 authorized shares, filed October 1, 2024) from its Certificate of Incorporation, as none are outstanding and none will be issued. The Board adopted resolutions on March 11, 2026, to effect this change under Section 151(g) of the Delaware General Corporation Law. The certificate was executed by CFO Christopher S. Guinta on March 25, 2026.
- ·Series A Certificate of Designations filed with Delaware Secretary of State on March 20, 2024.
- ·Series B Certificate of Designations filed with Delaware Secretary of State on October 1, 2024.
- ·Board resolutions adopted on March 11, 2026.
25-03-2026
Blue Water Acquisition Corp. IV, a SPAC led by Chairman and CEO Joseph Hernandez, announced the pricing of its $125 million initial public offering of 12,500,000 units at $10.00 per unit, expected to close on March 23, 2026. Units consist of one Class A ordinary share and one-half redeemable warrant (exercisable at $11.50 per share) and will trade on NYSE under 'BWIV.U' starting March 20, 2026, with separate trading of shares ('BWIV') and warrants ('BWIV.WS') thereafter. BTIG, LLC serves as sole book-running manager, with a 45-day option for underwriters to purchase up to 1,875,000 additional units.
- ·SEC registration statement declared effective March 19, 2026.
- ·Units expected to begin trading on NYSE under 'BWIV.U' on March 20, 2026.
- ·Separate trading of Class A ordinary shares ('BWIV') and warrants ('BWIV.WS') after unit separation.
- ·SPAC focus: high-potential companies in biotechnology, healthcare, and technology sectors.
25-03-2026
Twin Vee PowerCats Co. (NASDAQ: VEEE) announced the pricing of a best-efforts at-the-market offering of 6,491,900 shares of common stock at $0.384 per share, expecting gross proceeds of approximately $2.5 million before fees and expenses. The net proceeds will be used primarily for working capital and general corporate purposes, with the offering expected to close on March 24, 2026, subject to customary conditions. ThinkEquity is serving as the sole placement agent.
- ·Offering conducted under Nasdaq at-the-market rules pursuant to shelf registration statement on Form S-3 (File No. 333-293911), filed February 27, 2026, and effective March 5, 2026.
- ·Company manufactures boats under Twin Vee and Bahama Boat Works brands in Fort Pierce, Florida.
- ·Press release dated March 23, 2026; 8-K filed March 25, 2026.
25-03-2026
On March 19, 2026, Alena Brenner resigned as Executive Vice President, General Counsel, and Corporate Secretary of Cornerstone Building Brands, Inc. to pursue another professional opportunity, with no disagreement with the company, and will remain in her role until April 17, 2026; the company plans to initiate a search for a replacement. Separately, on March 24, 2026, CEO Gunner Smith entered into an agreement for two retention bonus awards, each $1,000,000, contingent on continued employment through December 31, 2026, and December 31, 2027, respectively.
- ·Award agreement details to be filed in Quarterly Report on Form 10-Q for period ending April 4, 2026
- ·Resignation notice date: March 19, 2026; 8-K filing date: March 25, 2026
25-03-2026
Apogee Therapeutics, Inc. entered into an underwriting agreement on March 24, 2026, to issue and sell 5,000,000 shares of common stock at $70.00 per share. The underwriters exercised in full their option to purchase an additional 750,000 shares. Net proceeds from the offering, including the option exercise, are expected to be approximately $377.4 million, with closing anticipated on March 26, 2026.
- ·Underwriting agreement includes indemnification of underwriters against certain liabilities under the Securities Act of 1933.
- ·Shelf registration statement (File No. 333-281503) effective August 12, 2024; final prospectus supplement filed March 25, 2026.
- ·Option exercisable for 30 days from March 24, 2026, and exercised in full on March 25, 2026.
25-03-2026
On March 19, 2026, Dr. Sheldon Paul resigned from the Board of Directors and the Cybersecurity and Technology Committee of CID HoldCo, Inc., effective immediately, ahead of his term expiring at the annual stockholders' meeting on April 30, 2026. The Board's Nominating and Corporate Governance Committee plans to search for a new independent director to fill the vacancy following the annual meeting. No successor has been appointed yet, and the resignation was notified during normal governance processes.
- ·Dr. Paul was one of two directors whose terms were scheduled to expire at the April 30, 2026 annual meeting.
- ·Company confirmed as emerging growth company.
- ·Principal executive offices at 5661 S Cameron St, Suite 100, Las Vegas, NV 89118.
25-03-2026
BioLargo, Inc. entered into a purchase agreement with Clearthink Capital Partners, LLC on March 20, 2026, committing to purchase up to $10.0 million of the company's common stock over a 36-month period at the company's discretion, subject to conditions including SEC registration effectiveness. As consideration, BioLargo issued 500,000 commitment shares to Clearthink with no cash proceeds. Proceeds from any future sales are expected for working capital and general corporate purposes, with no restrictions on future financings and an ownership limit of 9.99% for Clearthink.
- ·Regular purchases limited to the lesser of $500,000 or 300% of the average daily traded value over the prior 8 trading days, with a minimum of $25,000 per notice.
- ·At least five business days must elapse between purchase notices unless mutually agreed otherwise.
- ·Purchase price based on average of the two lowest daily closing prices during the 8 trading days preceding the notice.
- ·Clearthink prohibited from short sales or hedging establishing a net short position during the term.
- ·Company can terminate agreement anytime with one business day's notice at no cost.
25-03-2026
Ballston Spa Bancorp, Inc. (OTCQX: BSPA), holding company for Ballston Spa National Bank, completed a $26 million subordinated notes private placement to qualified institutional buyers and accredited investors to support its proposed merger with NBC Bancorp, Inc. (OTCID: NCXS), holding company for The National Bank of Coxsackie. The notes mature April 1, 2036, bear a fixed 7.375% interest rate through April 1, 2031 then floating at 90-day SOFR plus 378 basis points, are redeemable on or after April 1, 2031 or upon certain regulatory events, and qualify as Tier 2 capital. Net proceeds will fund the bank merger and general corporate purposes for the combined entity.
- ·Filing date: March 25, 2026
- ·Notes not registered under Securities Act of 1933; private placement only
- ·Griffin Financial Group LLC and Brean Capital LLC as placement agents; Luse Gorman, PC as legal counsel to BSNB; Stevens & Lee as legal counsel to placement agents
25-03-2026
Nuvve Holding Corp. entered into an amended and restated employment agreement with CFO David Robson effective March 22, 2026, featuring a $450,000 annual base salary, revenue-based performance bonuses, up to $20,000 automobile down payment, $1,500 monthly lease payments, equity awards, and 12 months severance upon qualifying termination. Separately, on March 19, 2026, the company's warrants (exercisable for one-half share at $11.50 per full share, issued in 2021 business combination) expired by their terms and were delisted from Nasdaq, with common stock NVVE continuing to trade.
- ·Employment agreement term: March 22, 2026 to March 22, 2027.
- ·Warrants issued in connection with initial business combination consummated on March 19, 2021.
- ·Agreement approved by Compensation Committee of the Board of Directors.
25-03-2026
PayPal Holdings, Inc. announced that Alyssa Henry, former CEO of Block’s Square business, has joined the Board of Directors, praised for her extensive experience in scaling payments and technology platforms. Gail J. McGovern, a board member since 2015, will retire and not stand for re-election at the upcoming Annual Meeting of Stockholders in May. The board will now consist of 12 directors, 11 independent, with Ann Sarnoff succeeding McGovern as chair of the Corporate Governance and Nominating Committee.
- ·Gail J. McGovern served on the Board since 2015
- ·PayPal empowers consumers and businesses in approximately 200 markets
25-03-2026
Effective March 23, 2026, Mark Guerin departed as Chief Financial Officer of Annovis Bio, Inc., with the departure not arising from any disagreement with the Company on operations, policies, or practices. The board anticipates appointing Maria Maccecchini, the current Chief Executive Officer, as Acting Chief Financial Officer until a permanent replacement is identified.
- ·Filing date: March 25, 2026
- ·Event date (earliest reported): March 23, 2026
25-03-2026
Nuburu, Inc. and Nuburu Defense, LLC entered into a letter of intent on March 19, 2026, with shareholders of Tekne S.p.A. to acquire a 70% equity interest through conversion of EUR 16.692 million in total convertible receivables (including a prior EUR 13 million from January 2026), a EUR 13 million capital increase for 25%, and EUR 6 million cash for an additional 10%, building on a prior 2.9% stake. The transaction is subject to Italian Golden Power authorization and includes plans for restructuring, potential industrial complex acquisition, drone manufacturing development, and a spin-off of non-core assets. While outlining strategic expansion, it carries risks such as regulatory approval delays and failure to realize anticipated benefits.
- ·Transaction effective subject to Presidenza del Consiglio dei Ministri GP Authorization
- ·Potential purchase or financial lease of industrial complex in Ortona (CH), Contrada Villa Caldari
- ·Share Transfer and Shareholder Convertible Loan Agreement effective January 13, 2026
25-03-2026
Exodus Movement, Inc. approved the 2026 Stock Incentive Plan in February 2026 via Board, Compensation Committee, and stockholder written consent, effective March 19, 2026. The plan authorizes 4,280,000 shares of Class A common stock for grants of stock options, restricted stock units, and other equity awards to employees, directors, and officers. It includes an automatic annual increase of 5% of outstanding common stock starting January 1, 2027, through 2036, subject to committee adjustment.
- ·Plan effective date: March 19, 2026
- ·Schedule 14C filed February 23, 2026; stockholders of record as of February 18, 2026
- ·Automatic share increase from January 1, 2027 to January 1, 2036
25-03-2026
Six Flags Entertainment Corporation (NYSE: FUN) appointed Richard Haddrill as Executive Chairman of the Board effective March 25, 2026, with Marilyn Spiegel serving as Lead Independent Director; this continues board refreshment, adding seven new directors since last summer and temporarily expanding the board to 11 members ahead of Jennifer Mason not standing for re-election at the 2026 Annual Meeting. The appointment follows John Reilly's CEO role in December 2025 and aims to enhance profitability and growth leveraging Haddrill's experience scaling Bally Technologies revenue from $550M to $1.2B and Manhattan Associates revenues by 150%. No current financial metrics or performance declines were disclosed.
- ·Six Flags operates parks across 16 states in the U.S., Canada, and Mexico, plus manages one amusement park in Saudi Arabia.
- ·Haddrill previously grew Bally Technologies share price by 7x and Manhattan Associates share price by 8x during his CEO tenures.
- ·Board size will revert to 10 members following Jennifer Mason's term expiration at 2026 Annual Meeting of Stockholders.
25-03-2026
Hecla Mining Company completed the sale of its Casa Berardi Mine subsidiary to Orezone Gold Corporation, receiving $160 million in cash and approximately 65.8 million Orezone common shares, plus entitlement to up to $321 million in deferred and contingent cash payments. The company also announced the full redemption of its remaining $263 million 7.25% Senior Notes due 2028, scheduled for April 9, 2026, using transaction proceeds and cash on hand. This transaction and deleveraging enhance Hecla's financial flexibility as the premier North American silver producer with assets including Greens Creek, Lucky Friday, and Keno Hill.
- ·Transaction originally announced on January 26, 2026
- ·Redemption notice delivered March 25, 2026; redemption date April 9, 2026
- ·Notes redeemed at par plus accrued and unpaid interest per indenture terms
25-03-2026
On March 19, 2026, the Compensation Committee of Star Equity Holdings, Inc. approved modifications to the 2025 Incentive Compensation Program, awarding bonuses to executives including $268,380 RSU to CEO Jeffrey E. Eberwein, $90,000 cash and $45,000 RSU to COO Richard K. Coleman, Jr., $45,743 cash and $53,021 RSU to CAO Matthew K. Diamond, and $150,000 cash to Jacob Zabkowicz of HTS. The Committee also adopted the 2026 Executive Incentive Compensation Plan with target opportunities such as $650,000 RSU for Eberwein and the 2026 LTIP for long-term incentives through 2028. No declines or flat metrics reported in compensation adjustments.
- ·Payouts under 2026 plans based on adjusted EBITDA targets, corporate cost targets, investment division EBITDA, qualitative objectives, and for Zabkowicz, HTS adjusted EBITDA and gross profit.
- ·2026 LTIP runs from January 1, 2026, to December 31, 2028, focused on increases in adjusted common shareholders’ equity book value.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)